Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trillium Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: semi_infinite who wrote (219)	10/8/2018 6:02:37 PM
From: Biomaven	Read Replies (3) \| Respond to of 294

>>Not sure what to make of the heavy volume on 10/4 with large drop in pricing. There have been some very large hedge funds that have closed of late - not biotech oriented to my knowledge, but who knows what they might have in some sub-fund. I don't think the price moves are related to the trials - more likely worries about an offering or just general impatience with their overall pace. The latest update was quite reassuring on safety. Let's see what ASH brings.